Cosette Launches First US Generic To AbbVie’s Rectiv
Commercial Shipments To Commence Imminently, With 180 Days Of CGT Exclusivity
Executive Summary
Approval of Cosette’s first US generic to Rectiv came with a six-month exclusivity as the originator drug had “inadequate generic competition,” but the company has 75 days to enter the market.